Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2592
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency ; volume:42 ; number:3 ; day:16 ; month:2 ; year:2022 ; pages:512-513 ; date:4.2022
Journal of clinical immunology ; 42, Heft 3 (16.2.2022), 512-513, 4.2022
- Urheber
-
Santamaria, Manuel
Neth, Olaf
Douglass, Jo A.
Krivan, Gergely
Kobbe, Robin
Bernatowska, Ewa
Grigoriadou, Sofia
Bethune, Claire
Chandra, Anita
Horneff, Gerd
Borte, Michael
Sonnenschein, Anja
Kralickova, Pavlina
Ramón, Silvia Sánchez
Langguth, Daman D.
Gonzalez‑Granado, Luis Ignacio
Alsina, Laia
Querolt, Montse
Griffin, Rhonda
Hames, Carrie
Mondou, Elsa
Price, Jeffrey
Sanz, Ana
Lin, Jiang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10875-022-01219-3
- URN
-
urn:nbn:de:101:1-2022070218511668904657
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Santamaria, Manuel
- Neth, Olaf
- Douglass, Jo A.
- Krivan, Gergely
- Kobbe, Robin
- Bernatowska, Ewa
- Grigoriadou, Sofia
- Bethune, Claire
- Chandra, Anita
- Horneff, Gerd
- Borte, Michael
- Sonnenschein, Anja
- Kralickova, Pavlina
- Ramón, Silvia Sánchez
- Langguth, Daman D.
- Gonzalez‑Granado, Luis Ignacio
- Alsina, Laia
- Querolt, Montse
- Griffin, Rhonda
- Hames, Carrie
- Mondou, Elsa
- Price, Jeffrey
- Sanz, Ana
- Lin, Jiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Treatment Satisfaction, Efficacy, and Tolerability of Low-Dose Diclofenac Epolamine Soft Capsules in Acute, Mild, or Moderate Musculoskeletal Pain: A Prospective Open-Label, Single-Arm Interventional Study
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study)
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Treatment Satisfaction, Efficacy, and Tolerability of Low-Dose Diclofenac Epolamine Soft Capsules in Acute, Mild, or Moderate Musculoskeletal Pain: A Prospective Open-Label, Single-Arm Interventional Study
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study)
Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Treatment Satisfaction, Efficacy, and Tolerability of Low-Dose Diclofenac Epolamine Soft Capsules in Acute, Mild, or Moderate Musculoskeletal Pain: A Prospective Open-Label, Single-Arm Interventional Study
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study)